BFC Planning’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
BFC Planning's JAZZ Position: Q3 2026 in Review
BFC Planning increased its Jazz Pharmaceuticals (JAZZ) stake by 18% in Q3 2026, buying an estimated $29.2K and bringing the position to 761 shares worth $176K. The position accounts for 0.01% of the portfolio, ranked #982.
BFC Planning first reported a position in JAZZ in Q3 2024 and has held it in 9 quarters since. 547 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- BFC Planning held 761 shares of Jazz Pharmaceuticals worth $176K as of Q3 2026.
- BFC Planning bought 118 Jazz Pharmaceuticals shares in Q3 2026, an estimated $29.2K.
- Jazz Pharmaceuticals made up 0.01% of BFC Planning's portfolio in Q3 2026, its #982 holding.
- BFC Planning first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- 547 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.